Therapeutic Goods Administration

Home/Tag: Therapeutic Goods Administration

The Stash, Volume 29

CANNA FINANCE: SET TO EMERGE FROM THE TROUGH OF DISILLUSIONMENT? In our Dec. 18, 2019 Stash report, we said that balance sheet strength will matter more than ever in 2020 as the cannabis industry funding environment tightens and deals dry up. We expand on this subject this week by analyzing how cannabis companies went from being [...]

2020-02-10T16:50:21+00:00February 5th, 2020|

The Stash, Volume 28

MEDIPHARM LABS: THE GLOBAL CANNABIS EXTRACTION LEADER IN THE MAKING MediPharm Labs (MEDIF) is well positioned to benefit from growth of the global cannabis extraction market to $23.7 billion by 2025. The launch of cannabis products in Canada in December has put the spotlight on Canadian cannabis players and their readiness to benefit from the expansion [...]

2020-02-10T17:11:49+00:00January 29th, 2020|

The Stash, Volume 27

HEMP: DRIVING SUSTAINABILE GROWTH IN THE CANNABIS INDUSTRY Hemp’s sustainable properties are expected to drive the 34% CAGR in the global industrial hemp market to $26.6 billion over the next five years. Hemp commonly refers to the industrial/commercial use of the cannabis stalk and seed for textiles, food, paper, body care products, detergents, plastics, and building [...]

2020-02-10T17:24:49+00:00January 22nd, 2020|